skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 22,813  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination
Material Type:
Article
Add to My Research

Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination

Annals of Neurology, 2021-08 [Peer Reviewed Journal]

2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/ana.26144

Digital Resources/Online E-Resources

2
Author Correction: Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation
Material Type:
Article
Add to My Research

Author Correction: Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation

Scientific reports, 2019-12, Vol.9 (1), p.19816-2, Article 19816 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-019-56282-5 ;PMID: 31852986

Full text available

3
Correction: Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach
Material Type:
Article
Add to My Research

Correction: Simultaneous administration of imipenem/cilastatin/relebactam with selected intravenous antimicrobials, a stewardship approach

PloS one, 2020-06, Vol.15 (6), p.e0235405-e0235405 [Peer Reviewed Journal]

COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Ghazi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Ghazi et al 2020 Ghazi et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0235405 ;PMID: 32579614

Full text available

4
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
Material Type:
Article
Add to My Research

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

The New England journal of medicine, 2017-01, Vol.376 (2), p.125-135 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1607427 ;PMID: 28076709

Full text available

5
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children
Material Type:
Article
Add to My Research

Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children

The Journal of clinical investigation, 2020-11, Vol.130 (11), p.5942-5950 [Peer Reviewed Journal]

COPYRIGHT 2020 American Society for Clinical Investigation ;COPYRIGHT 2020 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Nov 2020 ;2020 American Society for Clinical Investigation 2020 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci141113 ;PMID: 32701511

Full text available

6
Corrigendum to Physical Compatibility of Meropenem and Vaborbactam with Select Intravenous Drugs During Simulated Y-site Administration [Clinical Therapeutics 40 (2018) 261–269]
Material Type:
Article
Add to My Research

Corrigendum to Physical Compatibility of Meropenem and Vaborbactam with Select Intravenous Drugs During Simulated Y-site Administration [Clinical Therapeutics 40 (2018) 261–269]

Clinical therapeutics, 2018-11, Vol.40 (11), p.1956-1956 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright Elsevier Limited Nov 2018 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2018.09.013 ;PMID: 30336952

Full text available

7
96; AUDIT CYCLE OF INTRAVENOUS THROMBOLYSIS FOR STROKE: FROM GOOD TO BETTER
Material Type:
Article
Add to My Research

96; AUDIT CYCLE OF INTRAVENOUS THROMBOLYSIS FOR STROKE: FROM GOOD TO BETTER

Age and ageing, 2018-08, Vol.47, p.iii31 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com ;ISSN: 0002-0729 ;EISSN: 1468-2834 ;DOI: 10.1093/ageing/afy126.12

Full text available

8
TCT-622 Respiration-Related Variations in Pd/Pa Ratio and Fractional Flow Reserve in Resting Conditions and During Intravenous Adenosine Administration
Material Type:
Article
Add to My Research

TCT-622 Respiration-Related Variations in Pd/Pa Ratio and Fractional Flow Reserve in Resting Conditions and During Intravenous Adenosine Administration

Journal of the American College of Cardiology, 2019-10, Vol.74 (13), p.B610-B610 [Peer Reviewed Journal]

2019 ;Copyright Elsevier Limited Oct 1, 2019 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.08.738

Full text available

9
Letter: inconsistency in reporting of hypophosphataemia after intravenous iron—authors’ reply
Material Type:
Article
Add to My Research

Letter: inconsistency in reporting of hypophosphataemia after intravenous iron—authors’ reply

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.643-644 [Peer Reviewed Journal]

2017 John Wiley & Sons Ltd ;Copyright © 2017 John Wiley & Sons Ltd ;ISSN: 0269-2813 ;EISSN: 1365-2036 ;DOI: 10.1111/apt.14254 ;PMID: 28805331

Full text available

10
Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
Material Type:
Article
Add to My Research

Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke

The New England journal of medicine, 2020-05, Vol.382 (21), p.1981-1993 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2001123 ;PMID: 32374959

Full text available

11
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
Material Type:
Article
Add to My Research

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

The lancet oncology, 2019-09, Vol.20 (9), p.1239-1251 [Peer Reviewed Journal]

Elsevier Ltd ;2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30388-2 ;PMID: 31345627

Full text available

12
Trial of Intravenous Immune Globulin in Dermatomyositis
Material Type:
Article
Add to My Research

Trial of Intravenous Immune Globulin in Dermatomyositis

The New England journal of medicine, 2022-10, Vol.387 (14), p.1264-1278 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2117912 ;PMID: 36198179

Full text available

13
874-P: Use of Weight-Based Insulin to Reduce Hyperglycemia when Transitioning to Subcutaneous Insulin in MICU
Material Type:
Article
Add to My Research

874-P: Use of Weight-Based Insulin to Reduce Hyperglycemia when Transitioning to Subcutaneous Insulin in MICU

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1) [Peer Reviewed Journal]

Copyright American Diabetes Association Jun 1, 2021 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db21-874-P

Full text available

14
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial
Material Type:
Article
Add to My Research

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

The Lancet (British edition), 2019-03, Vol.393 (10176), p.1128-1137 [Peer Reviewed Journal]

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32003-8 ;PMID: 30853151

Full text available

15
Antibody‐mediated rejection: New approaches in prevention and management
Material Type:
Article
Add to My Research

Antibody‐mediated rejection: New approaches in prevention and management

American journal of transplantation, 2018-01, Vol.18 (S3), p.3-17 [Peer Reviewed Journal]

2017 The American Society of Transplantation and the American Society of Transplant Surgeons ;2017 The American Society of Transplantation and the American Society of Transplant Surgeons. ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.14584 ;PMID: 29292861

Full text available

16
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Material Type:
Article
Add to My Research

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial

Lancet neurology, 2021-04, Vol.20 (4), p.275-283 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2021 Elsevier B.V. ;2021. Elsevier Ltd ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(20)30494-4 ;PMID: 33743237

Full text available

17
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Material Type:
Article
Add to My Research

Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

The lancet oncology, 2018-05, Vol.19 (5), p.672-681 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 2018 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30139-6 ;PMID: 29602646

Full text available

18
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
Material Type:
Article
Add to My Research

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

The lancet oncology, 2021-08, Vol.22 (8), p.1081-1092 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00297-7

Full text available

19
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Material Type:
Article
Add to My Research

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

The Lancet (British edition), 2021-08, Vol.398 (10302), p.759-771 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01234-4

Full text available

20
Correction to: High aerosol generating potential
Material Type:
Article
Add to My Research

Correction to: High aerosol generating potential

British dental journal, 2020-08, Vol.229 (4), p.214-214 [Peer Reviewed Journal]

British Dental Association 2020. ;British Dental Association 2020 ;ISSN: 0007-0610 ;EISSN: 1476-5373 ;DOI: 10.1038/s41415-020-2086-5 ;PMID: 32855464

Full text available

Results 1 - 20 of 22,813  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (22,169)

Refine My Results

Creation Date 

From To
  1. Before 1969  (31)
  2. 1969 To 1982  (250)
  3. 1983 To 1996  (1,025)
  4. 1997 To 2011  (4,343)
  5. After 2011  (17,164)
  6. More options open sub menu

Language 

  1. English  (22,625)
  2. Japanese  (2,537)
  3. Portuguese  (128)
  4. French  (61)
  5. German  (54)
  6. Spanish  (43)
  7. Norwegian  (36)
  8. Russian  (17)
  9. Chinese  (16)
  10. Italian  (10)
  11. Polish  (7)
  12. Swedish  (7)
  13. Korean  (4)
  14. Turkish  (4)
  15. Serbian  (2)
  16. Romanian  (2)
  17. Slovak  (1)
  18. Czech  (1)
  19. Dutch  (1)
  20. Persian  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait